SynthesisThe Cochrane database of systematic reviews2005
Non-steroidal anti-inflammatory drugs for pain in women with endometriosis.
Synthesis in The Cochrane database of systematic reviews, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 5 syntheses or guidelines pooled it, 54 citations in OpenAlex.
- Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis.The Cochrane database of systematic reviews · 2017Pooled it
- Acupuncture for pain in endometriosis.The Cochrane database of systematic reviews · 2011Pooled it
- Endometriosis.BMJ clinical evidence · 2010Pooled it
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.BMJ (Clinical research ed.) · 2009Guideline
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.PLoS medicine · 2009Guideline
- Safety and pharmacology of AMY109, a long-acting anti-interleukin-8 antibody, for endometriosis: a double-blind, randomized phase 1 trial.F&S reports · 2025Article
- The role of self-management in endometriosis pain: insights from a cross-sectional survey in Germany, Austria, and Switzerland.Archives of gynecology and obstetrics · 2025Article
- Therapeutic Potential of Natural Resources Against Endometriosis: Current Advances and Future Perspectives.Drug design, development and therapy · 2024Review
- Endometriosis Pain Management: a Review.Current pain and headache reports · 2020Review
- Pain in Endometriosis.Frontiers in cellular neuroscience · 2020Review
- Novel Drug Targets with Traditional Herbal Medicines for Overcoming Endometriosis.Current drug delivery · 2019Review
- Bioinformatics approach reveals the key role of C‑X‑C motif chemokine receptor 2 in endometriosis development.Molecular medicine reports · 2018Article
- Clinical experience of long-term use of dienogest after surgery for ovarian endometrioma.Obstetrics & gynecology science · 2018Article
- Recurrence of endometriosis; risk factors, mechanisms and biomarkers; review of the literature.Journal of the Turkish German Gynecological Association · 2013Review
- Risk Factors for Endometriosis in a German Case-Control Study.Geburtshilfe und Frauenheilkunde · 2011Article
- Endometriosis and abdominal myofascial pain in adults and adolescents.Current pain and headache reports · 2011Review
- Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model.Endocrinology · 2011Article
- Clinical practice. Endometriosis.The New England journal of medicine · 2010Review
- Review
Corrections and comments
- Updated by
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndometriosis is a common gynaecological condition that affects women and can lead to painful symptoms and infertility. It affects women's quality of life greatly, impacting on their careers, everyday activities, sexual and non-sexual relationships, and fertility. Non-steroidal anti-inflammatory drugs (NSAIDs) are the most commonly used first-line treatment for endometriosis.
objectivesTo assess the effects of NSAIDs for the management of pain in women with endometriosis compared to placebo, other NSAIDs, other pain management drugs, or no treatment. SEARCH STRATEGY: We searched the Cochrane Menstrual Disorders and Subfertility Group Specialised Trials Register (May 2005) published in the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966 to May 2005), EMBASE (1980 to May 2005) and the reference lists from relevant publications. Experts in the field were also contacted for information about possible studies. SELECTION CRITERIA: We included all randomized controlled trials (RCTs) describing the use of NSAIDs in the treatment of endometriosis in women of all ages. DATA COLLECTION AND ANALYSIS: Two review authors (CA and SH) independently read and extracted data from each of the included studies. Crossover trials were analysed using the inverse variance method in RevMan to calculate the odds ratio for binary outcomes. MAIN
resultsTwo trials were identified but only one trial, with 24 women, was included in the analysis. Comparing NSAIDs (naproxen) to placebo, there was no evidence of a positive effect on pain relief (odds ratio (OR) 3.27, 95% CI 0.61 to 17.69) in women with endometriosis. There was also inconclusive evidence to indicate whether women taking NSAIDs (naproxen) were less likely to require additional analgesia (OR 0.12, 95% CI 0.01 to 1.29) or experience side effects (OR 0.46, 95% CI 0.09 to 2.47) when compared to placebo. AUTHORS'
conclusionsThere is inconclusive evidence to show whether NSAIDs (naproxen) are effective in managing pain caused by endometriosis. There is no evidence to show whether any individual NSAID is more effective than another. As shown in other Cochrane reviews, women using NSAIDs need to be aware of the possibility that these drugs may cause unintended effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.